SPEM vs XBI
SPDR Portfolio Emerging Markets ETF vs SPDR S&P Biotech ETF
- • SPEM has the lower expense ratio at 0.07% vs 0.35% for XBI.
- • SPEM pays a higher dividend yield (2.53%).
Side-by-side metrics
| Metric | SPEM | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.53% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $17.31B | $10.73B |
YTD return | 10.66% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.86 | 1.10 |
P/E ratio | 16.78 | — |
Last price | $51.69 | $164.28 |
Inception | — | — |
Issuer | State Street | State Street |
SPEM top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 14.57% |
| 0700.HK | Tencent Holdings Ltd | 2.72% |
| 2454.TW | MediaTek Inc | 1.81% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 1.78% |
| 2308.TW | Delta Electronics Inc | 1.12% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 0.93% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.83% |
| 3711.TW | ASE Technology Holding Co Ltd | 0.82% |
| 00939 | China Construction Bank Corp Class H | 0.81% |
| RIGD | Reliance Industries Ltd GDR - 144A | 0.80% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About SPEM
SPEM (SPDR Portfolio Emerging Markets ETF) is Low-cost emerging-market equity exposure. Managed by State Street, the fund carries $17.3B in assets under management, an expense ratio of 0.07%, a dividend yield of 2.53%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 14.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.